A recent meta-analysis of prospective cohort studies reported that higher FGF23 levels were associated with an elevated risk of all-cause mortality, cardiovascular disease events, cardiovascular mortality, stroke, and heart failure (18). This evidence concerns the gene FGF23 and cardiovascular disorder.